CSL BEHRING GMBH
ItalyAll drugs from this manufacturer
-
It is used to treat and prevent bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency).
Dosage form: solution for injection, powder and solvent
Active substance Dosage lonoctogen alfa - ATC: B02BD02
-
It is used to restore and maintain blood volume when it decreases critically, for example in the case of severe blood loss due to injury or following extensive burns.
Dosage form: solution for infusion
Active substance Dosage human albumin - ATC: B05AA01
-
ANDEMBRY is a medicine used to prevent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. HAE is a condition that causes recurrent episodes of rapid swelling in various parts of the body, such as the face, hands, feet, larynx, stomach, or intestine.
Dosage form: solution for infusion, in pre-filled syringe
Active substance Dosage garadacimab - ATC: B06AC07
-
Beriate is used to prevent or stop bleeding caused by a lack of Factor VIII in the blood (hemophilia A) and for the treatment of acquired Factor VIII deficiency.
Dosage form: solution for injection/infusion, powder and solvent for preparation of
Active substance Dosage factor viii - ATC: B02BD02
-
It is used for the treatment and prevention of type I and II hereditary angioedema (HAE) attacks, a congenital vascular system disease that causes sudden swelling of the hands, feet, face, lips, tongue, or abdomen.
Dosage form: solution for injection/infusion, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor - ATC: B06AC01
-
It is used in adult and pediatric patients for the preventive treatment of congenital factor XIII deficiency and for the treatment of surgical bleeding related to this deficiency.
Dosage form: solution for injection/infusion, powder and solvent for preparation of
Active substance Dosage factor xiii - ATC: B02BD07
-
It is used to prevent or treat bleeding caused by a deficiency (congenital or acquired) of certain vitamin K-dependent blood clotting factors (factors II, VII, IX, and X), when other specific products are not available.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human prothrombin complex - ATC: B02BD01
-
This medicinal product is used to prevent and treat bleeding caused by congenital factor VIII deficiency (haemophilia A) or von Willebrand disease.
Dosage form: solution for injection, powder and solvent
Active substance Dosage human coagulation factor viii - von willebrand factor - ATC: B02BD06
-
It is a gene therapy medicinal product used for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adults who have not developed antibodies against factor IX.
Dosage form: solution for infusion, concentrate
Active substance Dosage etranacogene dezaparvovec - ATC: B02BD16
-
Hizentra is used to increase immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin - ATC: J06BA01
-
It is used to prevent or stop bleeding caused by factor IX deficiency in patients of all ages with hemophilia B (also known as Christmas disease).
Dosage form: solution for injection, powder and solvent
Active substance Dosage albutrepenonacog alfa - ATC: B02BD04
-
It is used for people who do not produce a sufficient amount of antithrombin III. It is used to prevent blood clotting disorders (such as deep vein thrombosis or lung problems) and to treat disseminated intravascular coagulation caused by complications such as shock or systemic infections.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human antithrombin iii - ATC: B01AB02
-
It is used to increase immunoglobulin levels in the blood in patients with immunodeficiencies (primary or acquired) and to treat various inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain neuropathies.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin - ATC: J06BA02
-
It is used in adults suffering from a severe alpha-proteinase inhibitor deficiency (a hereditary disease also known as alpha-1 antitrypsin deficiency) who have developed pulmonary emphysema.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage human alpha1-proteinase inhibitor - ATC: B02AB02
-
It is used to prevent immunization in Rh(D)-negative women during pregnancy (or immediately after childbirth) when the fetus is Rh(D)-positive or if there is a risk of contact between the two blood systems. It is also used in Rh(D)-negative adults, children, or adolescents who have accidentally received Rh(D)-positive blood transfusions.
Dosage form: solution for injection
Active substance Dosage human rh0 immunoglobulin - ATC: J06BB01
-
It is used to treat bleeding in patients suffering from a congenital fibrinogen deficiency (hypo- or afibrinogenemia) that causes a tendency to bleed.
Dosage form: powder for solution for injection/infusion
Active substance Dosage human fibrinogen lyophilized - ATC: B02BB01
-
Voncento is used to prevent or stop bleeding caused by von Willebrand factor deficiency in von Willebrand disease (VWD) or factor VIII deficiency in hemophilia A. It is used only when desmopressin treatment is ineffective or cannot be administered.
Dosage form: solution for injection, powder and solvent
Active substance Dosage von willebrand factor - ATC: B02BD06